Influence of spontaneous hypertension and cardiac hypertrophy on the severity of ischemic arrhythmias in the rat
- 37 Downloads
Cardiac hypertrophy (CH) and hypertension (HT) are major determinants of sudden cardiac death in patients with coronary artery disease. To investigate the hypothesis that CH and HT increase the incidence of severe ventricular arrhythmias in an animal model, we performed a 30-min period of coronary artery ligation in anesthetized spontaneously hypertensive rats (SHR), normotensive Wistar Kyoto (WKY) and Wistar (W) rats. The incidence and duration of ventricular fibrillation resulting from coronary artery occlusion were significantly (p<0.01) increased in hypertensive rats compared to normotensive animals. The calcium entry blocker nicardipine was administered orally to SHR either chronically for 8 weeks (20 mg·kg−1 twice daily) or acutely as a single dose of 20 mg·kg−1. After long-term treatment with nicardipine, left ventricular hypertrophy index and systolic blood pressure were significantly (p<0.001) reduced when compared to vehicle-treated SHR, whereas a single administration of nicardipine only decreased blood pressure without affecting cardiac mass. In the long-term nicardipine-treated SHR group, acute coronary artery ligation induced significantly less ventricular fibrillation (p<0.05) and mortality (p<0.001) than in acutely nicardipine-treated or untreated SHR groups. In conclusion, the data suggest that the severity and incidence of lethal ventricular arrhythmias are more elevated in hypertensive than in normotensive rats and this may be related to the myocardial hypertrophic state.
Key Wordsspontaneoushypertension cardiachypertrophy nicardipine ventriculararrhythmia
Unable to display preview. Download preview PDF.
- 6.Byrom FB, Wilson C (1938) A plethysmographic method for measuring systolic blood pressure in the intact rat. J Physiol 93:301–304Google Scholar
- 8.Clark C, Foreman MI, Kane KA, Mc Donald FM, Parratt JR (1980) Coronary artery ligation in anaesthetized rats as a method for the production of experimental dysrhythmias and the determination of infarct size. J Pharmacol Method 3:357–368Google Scholar
- 23.Strauer BE, Klepzig M, Motz W (1986) Reversal of left ventricular and coronary hypertrophy following antihypertensive treatment. In: Kauffmann W, Bönner G, Lang R, Meurer KA (eds) Primary hypertension. Springer, Berlin Heidelberg New York Tokyo, pp 115–125Google Scholar
- 24.Takenaka T, Asano M, Shiono K, Shibasaki M, Inagaki O (1985) Cardiovascular pharmacology of nicardipine in animals. Br J Clin Pharmac 20:7S-22SGoogle Scholar
- 25.Tisné-Versailles J, Verscheure Y, Le Kim A, Pourrias B (1982) Comparison between the ventricular fibrillation thresholds of SHR and WKY: investigation of antidysrhythmic drugs. J Cardiovasc Pharmacol 65:1192–1197Google Scholar
- 26.Tracy CM, Epstein SE (1985) Sudden death and hypertrophic cardiomyopathy. Am Heart J 110:1326–1327Google Scholar